Gayer Charles K (CIK 1800110) reported 6 SEC Form 4 insider transactions across 1 companies over the past 18 months (most recent 2025-12-23). Recent activity: Sell BCRX (11,477 shares), Buy BCRX (14,142 shares), Buy BCRX (10,091 shares), Buy BCRX (50,000 shares), Buy BCRX (471,000 shares). Source: SEC Form 4.
| Date | Company | Role | Type | Shares | Value |
|---|---|---|---|---|---|
| 2025-12-23 | BIOCRYST PHARMACEUTICALS INC (BCRX) | President and CCO | Sell | 11,477 | $85,045 |
| 2025-12-23 | BIOCRYST PHARMACEUTICALS INC (BCRX) | President and CCO | Buy | 14,142 | $45,537 |
| 2025-12-23 | BIOCRYST PHARMACEUTICALS INC (BCRX) | President and CCO | Buy | 10,091 | $50,859 |
| 2025-12-23 | BIOCRYST PHARMACEUTICALS INC (BCRX) | President and CCO | Buy | 50,000 | $275,500 |
| 2025-12-19 | BIOCRYST PHARMACEUTICALS INC (BCRX) | President and CCO | Buy | 471,000 | $0 |
| 2025-12-16 | BIOCRYST PHARMACEUTICALS INC (BCRX) | President and CCO | Sell | 8,181 | $61,930 |
Source: SEC Form 4 filings · as of 2025-12-23